← Organizations
Sponsor / Institution
HaEmek Medical Center, Israel
Organization-level profile for a sponsor, institution, collaborator, or mixed-role entity. These profiles are separated from the primary industry company index when appropriate.
Programs
2
linked to organization
Strong Evidence
0
0 status confirmed
Details Checked
2
0 open data checks
Company / Institution Links
0 / 2
industry vs non-industry records
Competitive Density
3
Pipeline Velocity
15
Completion Signal
50
Programs by Stage
Phase 41
Observational/NA1
Trial / Program Status
Completed1
Discontinued1
Modality Mix
Diagnostic1
Small Molecule1
Indication Coverage
Hearing Loss1
Tinnitus1
Program Types
Diagnostic1
Therapeutic1
Population Tags
adult1
diagnostic-study1
observational1
pediatric1
sensorineural1
tinnitus1
Strong-Evidence Records
0 recordsNo strong-evidence records are linked to this organization yet.
Checked Records With Caveats
2 checked · 0 open checksCongenital Hypothyroidism Hearing-Loss Audiometry Study
Details checked
DiagnosticObservational/NADiscontinued
Withdrawn prospective observational case-control study using audiometry to estimate hearing-loss prevalence among children with congenital hypothyroidism.
Data checks: institution-led-study, registry-verified-study
HaEmek EMLA 5% Cream Tinnitus Study
Details checked
Small MoleculePhase 4Completed
Academic randomized double-blind Phase 4 study testing topical EMLA 5% cream, a lidocaine/prilocaine local anesthetic combination, applied post-auricularly for tinnitus symptoms versus cetomacrogol sham lotion. Cetomacrogol is the inactive comparator, not a separate tinnitus pipeline program.
Data checks: merged-generated-intervention-arms, institution-led-study